UCLB is the commercialisation company of UCL and its partner NHS Trusts. They bring to market truly world-leading, world-changing technologies, innovations that have a real and positive impact on people’s lives. UCLB the access point to the wealth of innovation and intellectual property emanating from UCL and partner hospitals including University College Hospital, Great Ormond Street Hospital, Royal Free Hospital and Moorfields Eye Hospital. They offer a number of services to assist the technology development process, from consultancy through to collaborative research, IP licensing and the creation of spinout companies and joint ventures to maximise the commercial potential of new discoveries, materials and processes.

Genedata is a bioinformatics company that specializes in developing software systems for the comprehensive analysis of genomes, transcriptomes, proteomes, metabolomes, and biochemical compounds. By working closely with key partners, the company combines its extensive product portfolio with expert scientific consulting services to offer tailor-made solutions for specific applications and multiple therapeutic areas. The company‘s solutions are key for moving the focus of life science research from highthroughput data acquisition to high-content data interpretation.

NIPD Genetics Ltd., a subsidiary of Medicover AB, is a company headquartered in Nicosia, Cyprus, that operates as biotechnology company. The firm was founded in 2010 by Philippos C. Patsalis, who is currently the CEO of the firm. Medicover AB acquired NIPD Genetics Ltd. on January 18, 2022 for $50.32 million.

Eurofins Genomics Europe Sequencing GmbH, part of Eurofins Scientific SE, is a German company located in Konstanz that provides technical, physical and chemical analysis services. It was founded in 2018. Thomas Brefort and Andreas Hinkel are the current co-CEOs of the firm.

EA Pharma Co., Ltd., a subsidiary of Eisai Co., Ltd., is a company headquartered in Tokyo, Japan, that manufactures pharmaceutical products for gastrointestinal disease.

AgeX is a biotechnology company focused on the development of novel therapeutics for age-related degenerative disease. AgeX’s mission is to apply the proprietary technology platform related to telomerase-mediated cell immortality and regenerative biology to address a broad range of diseases of aging. The current preclinical development efforts include two cell-based therapies derived from telomerase-positive pluripotent stem cells and two product candidates derived from the company’s proprietary induced Tissue Regeneration (iTR™) technology. AGEX-BAT1 and AGEX-VASC1 are cell-based approaches in the preclinical stage of development comprised of young regenerative cells modified using AgeX’s UniverCyte™ technology facilitating immune tolerance, formulated in HyStem® matrix, designed to correct metabolic imbalances in aging and to restore vascular support in ischemic tissues respectively. AGEX-iTR1547 is a drug-based formulation in preclinical development intended to restore regenerative potential in a wide array of aged tissues afflicted with degenerative disease using the company’s proprietary iTR technology.

Sequenom (NASDAQ: SQNM) is an American company based in San Diego, California. It develops enabling molecular technologies, and highly sensitive laboratory genetic tests for NIPT. Sequenom's wholly owned subsidiarity, Sequenom Center for Molecular Medicine (SCMM), offers multiple clinical molecular genetics tests to patients, including MaterniT21, plus a noninvasive prenatal test for trisomy 21, trisomy 18, and trisomy 13, and the SensiGene RHD Fetal RHD genotyping test.

BGI Tech Solutions Co., Ltd. (BGI-Tech), is a world leader in cutting-edge life sciences technology and premier scientific partner to the global research community. With a firm commitment to providing the highest quality services through our worldwide service network, BGI-Tech’s mission is to facilitate ground-breaking research, foster productive collaboration and accelerate scientific advancement. BGI-Tech was founded in 2012 and is headquartered in Shenzhen, China. BGI-Tech has lab facilities in Hong Kong, Wuhan (China),and Sacramento, California (United States). It also has branch offices in Europe, the Americas, Asia- Pacific, and in Beijing, Shanghai, and Guangzhou of mainland China. Its service network covers more than 100 countries and regions. Currently, BGI-Tech collaborates with over 10,000 organizations and 30,000 partners, providing highly reliable services for thousands of research projects, including several large-scale international genome projects. With diverse service experience, unique scientific expertise, BGI-Tech is committed to developing integrated omics platforms to revolutionize life science research, to accelerate the advancement of the life science industry and to address various health, agricultural, energy, and environmental issues to improve life and society.

GATC Biotech was a German company specialist in DNA and RNA sequencing for academic and industrial partners worldwide. The company offered sequencing and bioinformatics solutions from single samples up to large-scale projects. 'The Genome and Diagnostic Centre' focusing on Next and Third Generation sequencing was based in the headquarters in Constance, Germany. The fully automated NGS laboratories were certified under ISO 17025. The Sanger sequencing business was located in 'The European Custom Sequencing Centre' in Cologne, Germany. The proximity to Cologne Bonn Cargo GmbH served as the logistical hub within Europe.

Arizona Board of Regents oversees college activities. The company was founded in 1864 and is headquartered in Phoenix, AZ.

BGI Shenzhen Co., Ltd. engages in the equity investment and asset management. Its business scope includes research and development and sales of computer hardware and software and peripheral equipment technology; import and export of goods and technology; equity investment; investment in industrial development; and aquatic product farming and sales. The company was founded on August 21, 2008 and is headquartered in Shenzhen, China.

Nanjing Shihe Medical Equipment Co., Ltd., established on 2015-11-27, Business scope includes medical device production(Operate according to the scope listed in the license);Class I medical device sales,Serve;Class III medical device sales(Operate according to the scope listed in the license);biological reagent(Does not contain hazardous chemicals)research and development,Production,Sales,technology transfer,Technical Services;Enterprise Marketing Planning;Business Management Consulting;account Serive;vocational skills training;Research and development of biotechnology,Technical Services,technical consulting,technology transfer;Chemical raw materials and products(In addition to pesticides,Hazardous Chemicals),Computer hardware and software and auxiliary equipment(In addition to special products for computer information system security),knitted goods,Cleaning Products,bed linings,daily necessities(In addition to electric tricycle),Communication equipment,Sales of Stationery;Industrial Investment;Realtor;Self-operated and agent import and export business of various commodities and technologies.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

BGI Biotechnology (Shenzhen) Co., Ltd., established on 2019-08-27, Business scope includes general business items:engaged in biotechnology,Medical Diagnostic Technology,Diagnostic reagents,medical technology,Biological Technology,gene technology,health technology,Internet technology,Technology development in the field of information technology,technical consulting,Technical Services,Achievement transfer;Non-medical health information consultation;laboratory instrument,Development of laboratory reagents and consumables,Manufacturing and sales;IkindIIclass andIIIDevelopment of similar medical devices;Medical Supplies and Equipment,medical instruments,Pharmaceutical Intermediates,Chemical Products,Equipment,Operation and sales of electronic products;Import and export business of goods and technology;Biotechnology equipment rental;Data Processing and Storage Services,digital content service;Clinical Laboratory Services;[Items subject to approval by law,Business activities can only be carried out after approval by relevant departments];,The licensing program is:IkindIIclass andIIIProduction and operation of similar medical devices;Medical Supplies and Equipment,medical instruments,Pharmaceutical Intermediates,Chemical Products,Equipment,Production of electronic products;

Exact Sciences Development Co. LLC, part of EXACT Sciences Corp., is an American company. The firm engages in research and development diagnostic test for cancer.

Guangzhou Baseline Medical is committed to building a world-class clinical application of high-throughput sequencing and R & D platform to become the leading global provider of precision medical solutions. The company's core team has more than 20 years of senior industry experience, involved in cancer genomics, genetics and bioinformatics and other fields. Based on its core technical advantages, the Company aims at precision medicine, establishes a cooperative relationship with middle and downstream enterprises in the industry, and forms a complete industrial chain from academic research to clinical product transformation. It has also established close cooperation with many large-scale third-party inspection agencies including Illumina, Well-known domestic and foreign hospitals and research institutes to establish cooperative relations, the development of a series of independent intellectual property rights and international competitiveness of clinical testing products for patients, doctors and medical institutions to provide accurate, convenient and comprehensive services.

Assistance Publique des Hôpitaux de Paris SA the company is headquartered in Paris, France.

Suzhou Genga Medical Laboratory Co., Ltd., established on 2017-06-26, Business scope includes medical testing services;Technology development in the field of medical technology,Technical Services,technology transfer,technical consulting;Health Management Consulting;Sales:Instrumentation,Equipment,Chemical Products,Computer hardware and software and auxiliary equipment;Engage in the import and export of the above commodities and technologies;Industrial Investment,Investment Advisory.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.) licensed items:Class III medical device business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Sales of Class I Medical Devices;Sales of Class II Medical Devices(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Shenzhen Jiyinga Medical Laboratory, established on 2018-07-13, Business scope includes general business items:medical service;technology development,Technical Services,technology transfer,technical consulting;Natural science research and experimental development;Engineering and Technology Research and Experimental Development;Medical Research and Experimental Development;health management;Health Advisory;Sales instrumentation,Equipment,Chemical Products(Free of Hazardous Chemicals),Computer hardware and software and auxiliary equipment;Import and export,Technology Import and Export,Agent import and export;Investment.(Enterprises independently choose operating projects according to law,Carry out business activities;Medical services and items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.),The licensing program is:First,two,Production of Class III Medical Devices,Sales.